Cargando…
Dysregulated EGFR pathway in serum in early-stage breast cancer patients: A case control study
The epidermal growth factor receptor (EGFR) and its ligands are involved in cancer pathogenesis and they might serve as circulating biomarkers. The current study aims to investigate if abnormal pre-treatment serum levels of EGFR and EGFR ligands are present in women with early-stage breast cancer an...
Autores principales: | Kjær, Ina Mathilde, Olsen, Dorte Aalund, Brandslund, Ivan, Bechmann, Troels, Jakobsen, Erik Hugger, Bogh, Søren Bie, Madsen, Jonna Skov |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174424/ https://www.ncbi.nlm.nih.gov/pubmed/32317675 http://dx.doi.org/10.1038/s41598-020-63375-z |
Ejemplares similares
-
Prognostic impact of serum levels of EGFR and EGFR ligands in early-stage breast cancer
por: Kjær, Ina Mathilde, et al.
Publicado: (2020) -
Phase II trial of delta-tocotrienol in neoadjuvant breast cancer with evaluation of treatment response using ctDNA
por: Kjær, Ina Mathilde, et al.
Publicado: (2023) -
New Approach for Interpreting Changes in Circulating Tumour Cells (CTC) for Evaluation of Treatment Effect in Metastatic Breast Cancer
por: Horn, Peer, et al.
Publicado: (2014) -
Predicting brain metastases of breast cancer based on serum S100B and serum HER2
por: BECHMANN, TROELS, et al.
Publicado: (2013) -
Rapid SARS-CoV-2 Detection Using Electrochemical Immunosensor
por: Mojsoska, Biljana, et al.
Publicado: (2021)